DOCSLIB.ORG

Beckman Historical Collection 002 Finding Aid Created and Encoded Into EAD by Kenton G

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Beckman Historical Collection 002 Finding Aid Created and Encoded Into EAD by Kenton G Beckman Historical Collection 002 Finding aid created and encoded into EAD by Kenton G. Jaehnig. Last updated on September 23, 2021. Science History Institute Archives Beckman Historical Collection Table of Contents Summary Information....................................................................................................................................3 Biography/History..........................................................................................................................................4 Scope and Contents....................................................................................................................................... 7 Administrative Information........................................................................................................................... 8 Related Materials........................................................................................................................................... 9 Controlled Access Headings..........................................................................................................................9 Collection Inventory.................................................................................................................................... 11 Series I. Arnold O. Beckman Files....................................................................................................... 11 Series II. Business Activities Files........................................................................................................36 Series III. Corporate and Division Histories.........................................................................................74 Series IV. Press Releases...................................................................................................................... 86 Series V. Financial Records.................................................................................................................. 92 Series VI. In-House Publications........................................................................................................ 103 Series VII. Salvadoran Kidnappings and Negotiations.......................................................................117 Series VIII. Clippings and Advertisements.........................................................................................120 Series IX. Patent Files......................................................................................................................... 124 Series X. Photographic Materials........................................................................................................128 Series XI. Bulletins..............................................................................................................................177 Series XII. Audio-Visual Materials.....................................................................................................191 Series XIII. Oversized......................................................................................................................... 224 Series XIV. Instructions and Manuals................................................................................................ 226 - Page 2 - Beckman Historical Collection Summary Information Repository Science History Institute Archives Creator Beckman, Arnold O. Creator Beckman Coulter (Firm) Title Beckman Historical Collection Call number 002 Date [inclusive] 1911-2011 Date [bulk] 1935-2004 Extent 137.2 linear feet (131 boxes (81 record boxes, 10 hollinger boxes, 3 half hollinger boxes, 26 photo album boxes, 2 videotape boxes, 1 audiocassette box, 4 cd-rom boxes, and 4 oversized boxes)) Language Collection materials are mostly in English. A small amount of material in German is also included in this collection. Abstract Business records, correspondence, research files, financial records, photographs, publications, and audio-visual materials of American scientist and industrialist Arnold O. Beckman and the American scientific and medical instrument manufacturer Beckman Coulter, Incorporated. Cite as: Item Description, Box Number, Folder Number, Beckman Historical Collection, 1911-2011, Science History Institute Archives. - Page 3 - Beckman Historical Collection Biography/History Dr. Arnold Orville Beckman, the founder of scientific and medical instrument manufacturer Beckman Coulter, Incorporated, was a prominent American scientist, inventor, industrialist, and philanthropist. Born in Cullom, Illinois on April 10, 1900, Beckman first became interested in chemistry at the age of nine, when he found a copy of J. Dorman Steele's textbook, Fourteen Weeks in Chemistry in his family's home. Encouraged by his father, he converted a tool shed into a laboratory and developed his interest in chemistry over the course of his childhood and adolescence. Beckman graduated as class valedictorian from University High School in Normal, Illinois in 1918 and served in the United States Marine Corps during the last months of World War I. After his discharge from the Marine Corps in 1919, Beckman furthered his education by earning a bachelor's degree in chemical engineering (1922) and a master's degree in physical chemistry (1923) from the University of Illinois at Urbana-Champaign. He entered the California Institute of Technology as a doctoral student in 1923, but interrupted his studies after one year to work for Western Electric Company in New York City, where he became interested in electronics. Beckman resumed his graduate studies at Cal Tech in 1926. While still a graduate student, he obtained the first of fourteen patents awarded to him in his lifetime. His first patent was for a "signaling device", a buzzer attached to an automobile's speedometer, which was designed to help drivers regulate their speed. Beckman earned his Ph.D. in photochemistry from Cal Tech in 1928. From 1928 to 1940, Beckman served as a chemistry professor at Cal Tech. He became fascinated with scientific instrumentation and increasingly focused his attention upon this area as his academic career progressed. In addition to his faculty duties, Beckman was retained as a consultant by a number of businesses, and served as an expert witness in a number of legal cases involving chemistry, which included the Church Horse Doping Case and the Cox and Weatherill Oil Swindle Case. In 1934, while still a professor at Cal Tech, Beckman was retained as a consultant by National Postal Meter Company to develop a non-clogging ink for postal meters. Beckman developed a non-clogging ink, albeit one noted for its rancid odor. He also invented and patented two appliances to apply the ink: an inking reel and an inking device. To manufacture the ink and develop the inking appliances, National Postal Meter set up a subsidiary named National Inking Appliance Company, and named Beckman Vice- President and Manager. Setting up shop in a garage in Pasadena, California, Beckman soon found that there was not much of a market for these products and this venture was not particularly successful. Around the same time, Beckman was approached by Glen Joseph, a chemist for the California Fruit Growers Exchange, who needed an electrochemical device to measure the acidity of lemon juice. In response to this need, Beckman invented and patented the first commercially successful pH meter. Later named the Model E, Beckman's new pH meter worked so well that he was soon asked to build more of them. Seeing a line of business that was potentially more profitable than postal meter ink and inking appliances, Beckman shifted his firm's focus to the manufacture of pH meters. To reflect this change, National Inking Appliance Company was renamed National Technical Laboratories on April 8, 1935. Now independent of - Page 4 - Beckman Historical Collection National Postal Meter Company, with Beckman serving as Vice-President and owning a 10% stake, the company sold eighty-seven Model E pH meters in its first year. By 1939, National Technical Laboratories had experienced significant growth, which led to Beckman being named President of the company. In 1940, Beckman resigned his professorship at Cal Tech to devote full-time attention to his firm. That same year, the company moved into its own building in South Pasadena, California. National Technical Laboratories expanded its line of instruments during World War II and made a number of notable contributions to the American war effort. Under Beckman's leadership, the firm introduced the Helipot Potentiometer in 1940, which became a vital component in American military radar systems. Beckman also spearheaded the development of the DU Spectrophotometer. Introduced in 1941, the DU Spectrophotometer revolutionized biochemical analysis and found numerous applications during the war, including the development and production of penicillin. In 1942, National Technical Laboratories introduced the IR-1 Spectrophotometer, an infrared spectrophotometer that was used in the development of synthetic rubber. Under Beckman's direction, National Technical Laboratories further contributed to the war effort by building micro-microammeters and dosimeters, both of which were used by the Manhattan Project. In addition to running National Technical Laboratories, Beckman founded two additional business concerns during World War II. In 1942, he established Arnold O. Beckman, Incorporated to manufacture the Pauling Oxygen Analyzer, an instrument for measuring oxygen levels in submarines and aircraft. This company
Load more

Recommended publications
  • Participant List
    Participant list Please find below a list of current participants in theAustralian Life Sciences Remuneration Review. For a complete list by super sector, sector and segment refer to Mercer WIN®. A. Menarini Australia B Braun Avitum Australia Cardinal Health AbbVie Australia Bausch & Lomb (Australia) Cepheid Abbott Australasia Baxter Healthcare Cochlear Acrux Bayer Coloplast Australia Alcon Beckman Coulter - Diagnostics Convatec (Australia) Alere Beckman Coulter - Life Sciences CooperVision Australia Allergan Becton Dickinson DH Dental Alphapharm Besins Healthcare Australia DSM Nutritional Products Amgen Biogen Idec Australia Device Technologies Aust Ascom Australia Biomerieux Australia Ecolab Aspen Australia Blackmores Edwards Lifesciences Astellas Pharma Boehringer Ingelheim Eisai Australia AstraZeneca Boston Scientific International Elanco Australasia Australian Nuclear Science and Technology Boucher & Muir Eli Lilly Australia Organisation (ANSTO) Bristol-Myers Squibb Evolution Health Australian Pharmaceutical Industries CSL Ferring Pharmaceuticals B Braun Australia © September 2020 Mercer Consulting (Australia) Pty Ltd Australian Life Sciences Remuneration Review 4.1 Participant list Fresenius Kabi Australia Integrated DNA Technologies (IDT) Merck Serono Fresenius Medical Care Australia Invisalign Australia Mindray Medical International GE Australia Healthcare Ipsen Molnlycke Health Care GN Netcom Australia J&J Pacific Mundipharma Galderma Australia Janssen-Cilag - Australia Nevro Medical Australia Getinge Johnson & Johnson Medical
    [Show full text]
  • 69-10599 GOMES, Benedict, 1933
    - - ~- ... - - - .- - _. - - .. ~. - - - I' This dissertation has been 69-10,599 microfilmed exactly as received GOMES, Benedict, 1933- BEEF LIVER MITOCHONDRIAL AMINE OXIDASE; PURIFICATION AND STUDIES ON SOME PHYSICAL AND CHEMICAL PROPERTIES. University of Hawaii, Ph.D., 1968 Biochemistry University Microfilms, Inc., Ann Arbor, Michigan BEEF LIVER MITOCHONDRIAL AMINE OXIDASE; PURIFICATION AND STUDIES ON SOME PHYSICAL AND CHEMICAL PROPERTIES A DISSERTATION SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERSITY OF HAWAII IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN BIOCHEMISTRY SEPTEMBER 1968 by BENEDICT GOMES Dissertation Committee: Kerry T. Yasunobu, Chairman Morton Mandel Lawrence H. Piette Robert H. McKay John B. Hall DEDICATION TO MY MOTHER Acknowledgements To the East-West Center of the University of Hawaii; the National Institute of Health; and the Hawaii Heart Association for fellowships. To Drs. I. Igaue and H. J. Kloepfer for their assistance in the enzyme purification. To Mrs. Tomi Haehnlen and Kazi Sirazul Islam for drawing figures. TABLE OF CONTENTS LIST OF TABLES ••••••••••••••••••••••.•••••••••• vi LIST OF FIGURES •••••.•.••••••••••.••••••••••••. viii ABBREVIATIONS .••••••.•.•.••••••••••.••••••••••• xi ABSTRACT •..•.•.•.••.•••••••••••••••.••••••••••. xii I. INTRODUCTION. •••.•.•••.••••••••..•••••••••. 1 A. Historical Background of Amine 2 Oxidase Studies •••..••••••••••.•••• B. Physiological Significance •.••••••• 5 C. Statement of the Problem........... 6 II. MATERIALS AND METHODS .•••••••.••••••••••.••
    [Show full text]
  • The World Turns to Us
    The world turns to us 2009 Annual Report 75 years and still advancing Company Profi le Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. Our diagnostic systems are found in hospitals and other critical care settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs. Hospital laboratories are our core clinical diagnostic customers. Our life science customers include pharmaceutical and biotechnology companies, medical schools and research institutions. Beckman Coulter has an installed base of more than 200,000 clinical and research systems operating in laboratories around the world. About 81% of Beckman Coulter’s $3.3 billion annual revenue comes from recurring sources, such as consumable supplies (including reagent test kits), service and lease payments. Beckman Coulter 2009 Annual Report P1 For 75 years, the world has turned to us to help fi nd answers to the mysteries of medical science. We’re proud to say we’ve solved many of them. Today, with a focus on recurring revenue growth, operating excellence and quality, we are delivering steady results to shareholders even in these uncertain times. Our unwavering dedication to improving patient health and reducing the cost of care defi nes who we are. Our track record of creating the industry’s most productive products and our broad and growing capabilities in the core laboratory clearly position us as a leader in biomedical testing.
    [Show full text]
  • Metabolism of Neoplastic Tissue II. a Survey of Enzymes of the Citric Acid Cycle in Transplanted Tumors*
    Metabolism of Neoplastic Tissue II. A Survey of Enzymes of the Citric Acid Cycle in Transplanted Tumors* CHARLES E. WENNER,t MORRIS A. SPIRTES, AND SIDNEY WEINHOUSE (The Lankenau Hospital Research institute and the Instituiefor Cancer Research, and the Department of Chemistry, Temple University, Philadelphia, Pa.) Recent isotopic tracer studies of tumor metabo on homogenates of the whole tissue or on extracts lism indicated that the neoplastic cell can carry out of acetone powders. All assays were carried out in the complete oxidation of glucose and fatty acids the zero order range of substrate concentration via the citric acid cycle (84, 85). In view of a strong and with proportionality of enzyme activity and body of evidence against the occurrence of the tissue concentration—these conditions having Krebs cycle in tumors (18, 19), further information been established by preliminary experiments. De bearing on this problem seemed desirable. Accord tails of the procedures are given in the individual ingly, a survey was undertaken of various trans sections and in the table headings. The prepara planted neoplasms for their content of citric acid tions of homogenates will be described in the indi cycle enzymes. In order to obtain a “profile―of vidual assays. The acetone powder extracts were enzymatic activity, approximate assays were car prepared as follows : the freshly dissected tissue ned out of those enzymes for which straightfor (pooled from four to six animals) was homogenized ward methods were available; these included for 1 minute at 2°C. in a Waring Blendor with 2 malic, isocitric, and a-ketoglutaric dehydroge volumes of acetone.
    [Show full text]
  • Eprocurement Small Order Process: Vendors with Item Catalogs
    eProcurement Small Order Process: Vendors with Item Catalogs Updated April 18, 2012 V000142495 ABCAM INC V000137051 ILLUMINA INC V000081265 ACO MEDICAL SUPPLY V000014509 INTERMOUNTAIN SCIENTIFIC V000125369 ACTIVE MOTIF V000080847 INTREX COMPUTERS INC V000112094 AFFYMETRIX INC V000006118 INVITROGEN CORPORATION V000114793 AGILENT TECHNOLOGIES INC V000130596 INVIVOGEN V000000082 ALLTECH ASSOCIATES INC V000005714 JACKSON IMMUNORES V000000118 AMRESCO V000001442 JACKSON LAB V000152997 ANASPEC INC V000001558 LABORATORY SAFETY V000132756 ASYLUM RESEARCH CORP V000047258 LABREPCO INC V000000126 ATCC V000108167 LEICA MICROSYSTEMS V000068824 ATLANTA BIOLOGICALS V000088788 LI-COR INC V000162435 ATLANTIC FITNESS V000111733 LIST BIOLOGICAL LABS V000000307 BASI V000002832 LONZA WALKERSVILLE INC V000000261 BD BIOSCIENCES V000149811 MATRIX TECH V000000259 BECKMAN COULTER V000135360 MEDICAL SPECIALTIES V000176191 BENCHMARK TECH V000022962 MIDWEST SCIENTIFIC V000101618 BETHYL LABS V000078901 MILTENYI BIOTEC INC V000159330 BIO BASIC V000008542 MOLECULAR DEVICES INC V000004901 BIOGENIX LABORATORIES V000001340 MP BIOMEDICALS V000145647 BIOLEGEND V000188293 NETA SCIENTIFIC INC V000157241 BIOLINE USA INC V000186184 NEWEAST BIOSCIENCES V000112934 BIOLOGICAL SPECIALTY CORP V000001880 NEW ENGLAND BIOLABS INC V000000303 BIO-RAD V000004850 NEWPORT V000000305 BIO-TEK INSTRUMENTS V000052248 NIKON INSTRUMENTS INC V000000349 BRAINTREE V000167597 OCEAN OPTICS V000190375 BUTLER SCHEIN V000001937 OLYMPUS AMERICA INC V000000429 CAMCOR V000139707 OPEN BIOSYSTEMS V000000454
    [Show full text]
  • Table of Contents Petition of Scientists Sceptical of Anthropogenic Global Warming
    PETITION OF SCIENTISTS SCEPTICAL OF AGW – 31,000 SCIENTISTS DISAGREE Table of Contents Purpose of Petition ............................................................................................... 1 Summary of Peer-Reviewed Research ......................................................................... 1 Qualifications of Signers ......................................................................................... 2 How Petition is Circulated ...................................................................................... 2 Full List of 31,486 US based Scientists ........................................................................ 3 Petition of scientists sceptical of Anthropogenic Global Warming Petition Project - http://www.petitionproject.org/ and http://www.oism.org/pproject/s33p36.htm Purpose of Petition The purpose of the Petition Project is to demonstrate that the claim of “settled science” and an overwhelming “consensus” in favour of the hypothesis of human-caused global warming and consequent climatological damage is wrong. No such consensus or settled science exists. As indicated by the petition text and signatory list, a very large number of American scientists reject this hypothesis. Publicists at the United Nations, Mr. Al Gore, and their supporters frequently claim that only a few “sceptics” remain – sceptics who are still unconvinced about the existence of a catastrophic human- caused global warming emergency. It is evident that 31,486 Americans with university degrees in science – including 9,029
    [Show full text]
  • Copyrighted Material
    pter O ha n C e An Historic Overview of Venture Capitalism • Those who cannot remember the past are condemned to repeat it. —George Santayana Why is an historical overview of VC important? Because history does in fact repeat itself, and a study of history allows us to frame an ­understanding of the present and the future. The playersCOPYRIGHTED and the investment climate MATERIAL change, but the entrepreneur’s innate instinct to risk capital for a return is no different today from what it was when John D. Rockefeller became America’s first billionaire in 1900. When Andrew c01.indd 1 10-12-2013 8:50:11 [2] The Little Book of Venture Capital Investing Carnegie joined forces with his childhood friend, Henry Phipps, to form Carnegie Steel in 1892, they were driven by the same conviction to improve the status quo as are the idealistic dream chasers of the twenty-first century. It was these early trailblazers who paved the way and developed the techniques that have laid the foundation for VC as we know it today. Arguably, historians will debate the nature of history and its usefulness. This includes using the discipline as a way of providing perspective on the problems and opportu- nities of the present. I believe it to be an important tool in providing a systematic account and window to the future. It is patently dishonest and irresponsible to perpetuate the popular mythology that those who created great wealth in America are to be despised and that there are no useful les- sons to be learned from an objective, historical review of their contributions to the subject at hand.
    [Show full text]
  • Lecture Notes 18
    617 Lecture #18 of 26 618 Liquid-Junction Potentials Chapter 2 619 Q: What’s in this set of lectures? A: B&F Chapter 2 main concepts: ● “Section 2.1”: Salt; Activity; Underpotential deposition ● Section 2.3: Transference numbers; Liquid-junction potentials ● Sections 2.2 & 2.4: Donnan potentials; Membrane potentials; pH meter; Ion-selective electrodes So, in summary, five equations for junction potentials… 620 … why do they all include “kinetic” transport properties? (α) LJ, Type 1 (β) LJ, Type 2 LJ, Type 3 (Henderson) the only model that, with (α) one salt and one interface, Donnan (β) definitely equilibrates Goldman (GHHK) 621 http://biophys.med.unideb.hu/old/pharmacy/Donnan%20angol2009.pdf … but first, what about “the fifth” equation? 622 … the Goldman–(Hodgkin–(Huxley)–Katz)) equation! permeabilities http://en.wikipedia.org/wiki/Membrane_potential … no need for a squid giant axon (H & H) 623 (diameter ≈ 0.5 mm)… www.highlands.edu/academics/divisions/scipe/biology/faculty/harnden/2121/notes/nervous.htm ~110 years of Ion-Selective Electrodes (ISEs)… 624 1906 – Max Cremer discovers that a thin glass membrane separating two solutions develops a potential related to the difference in pH between them 1920’s – Duncan MacInnes & Malcolm Dole discover a glass suitable for glass pH electrodes… 1933 – Arnold Beckman markets first pH electrode in Fullerton, CA for measuring acidity of lemon juice… the Beckman G 1905 Walter Nernst proposes 3rd Law of Thermodynamics; In Bern, Einstein describes PE effect, Brownian motion, and Special Rel. 1900
    [Show full text]
  • Chemistry 5 (Instrumental)
    CHEMISTRY 5 (INSTRUMENTAL) AGRICULTURAL BIOTECHNOLOGY, LEVEL 2 By Associate Prof. Mohamed Frahat Foda 2021.04.08 CONTENTS • What is a spectrophotometer? • Principle of Spectrophotometer • Instrumentation of Spectrophotometer •Prisms. •Grating. • Applications • References WHAT IS A SPECTROPHOTOMETER? • A spectrophotometer is an instrument that measures the concentration of solutes in solution by measuring the amount of light absorbed by the sample in a cuvette at any selected wavelength. • A spectrophotometer is a process where we measured absorption and transmittance of monochromatic light in terms of ratio or a function of the ratio, of the radiant power of the two beams as a functional of spectral wavelength. These two beams may be separated in time, space or both. It operates on Beer’s law Link labcompare.com SPECTROPHOTOMETER SPECTROPHOTOMETER: ▪ PRINCIPLE, ▪ INSTRUMENTATION, ▪ APPLICATIONS ➢ Scientist Arnold O. Beckman and his colleagues at the National Technologies Laboratory (NTL) invented the Beckman DU spectrophotometer in 1940. https://microbenotes.com/ • The spectrophotometer technique is to measure light intensity as a function of wavelength. It does this by diffracting the light beam into a spectrum of wavelengths, detecting the intensities with a charge-coupled device, and displaying the results as a graph on the detector and then on the display device. 1.In the spectrophotometer, a prism (or) grating is used to split the incident beam into different wavelengths. 2.By suitable mechanisms, waves of specific wavelengths can be manipulated to fall on the test solution. The range of the wavelengths of the incident light can be as low as 1 PRINCIPLE to 2nm. 3.The spectrophotometer is useful for measuring the absorption spectrum of a compound, that is, the absorption of light by a solution at each wavelength.
    [Show full text]
  • 2017 INVESTOR & ANALYST DAY December 14, 2017
    2017 INVESTOR & ANALYST DAY December 14, 2017 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, deterioration of or instability in the economy, the markets we serve and the financial markets, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify, consummate and integrate appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to integrate the recent acquisitions of Pall Corporation and Cepheid and achieve the anticipated benefits of such transactions, contingent
    [Show full text]
  • AAS and ICP-AES Analysis of the Iron-Sulfur Cluster in Yojg (Napf) Protein of Aeg-46.5 Operon in Escherichia Coli
    Notes Bull. Korean Chem. Soc. 2003, Vol. 24, No. 12 1849 AAS and ICP-AES Analysis of the Iron-sulfur Cluster in YojG (NapF) Protein of aeg-46.5 Operon in Escherichia coli Hyo Ryung Kim, Yong Chan Lee, Jae Seon Won, and Mu Hyeon Choe* College of Life Science and Graduate School of Biotechn이ogy, Korea University, Seoul 136-701, Korea Received September 27, 2003 Key Words : YojG, NapF, aeg-46.5, Iron-sulfur cluster, Electron transfer The E. coli aeg-46.5 region was identified by anaerobically second major family of electron carrier besides cytochromes. expressed lacZ fusions.1,3 In the course of the E. coli These proteins were shown to contain complexes of iron and genome-sequencing project, Richterich et al.4 identified a cysteinate (Cys) sulfur atoms and to incorporate inorganic or chromosomal gene cluster in the centisome 49 region that acid-labile sulfur in the form of two-and four iron clusters. contains several open reading frames (ORFs) with strong They are ubiquitous in living matter and contain sites with similarity to the cytochrome c biosynthesis genes of one or eight iron atoms, sometimes with multiple occur­ Bradyrhizobium japonicum and Rhodobacter capsulatus? rences of the smaller clusters in the same protein molecule.11 These ORFs (yej WVUTSRQP) appear to represent the 3'- In this study, the yojG gene from #372 of Kohara library half of the putative aeg-46.5 operon, whose expression was was cloned into pMAL-c2 vector to prepare the YojG protein shown to be induced under anaerobic growth conditions in and analyze the iron-sulfur contents of the protein with the presence of nitrate and nitrite and it was proposed to call sensitive chemical detection method.
    [Show full text]
  • Case No COMP/M.6175 - DANAHER/ BECKMAN COULTER
    EN Case No COMP/M.6175 - DANAHER/ BECKMAN COULTER Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Article 6(1)(b) NON-OPPOSITION Date: 16/06/2011 In electronic form on the EUR-Lex website under document number 32011M6175 Office for Publications of the European Union L-2985 Luxembourg EUROPEAN COMMISSION Brussels, 16.06.2011 C(2011)4423 In the published version of this decision, some information has been omitted pursuant to Article PUBLIC VERSION 17(2) of Council Regulation (EC) No 139/2004 concerning non-disclosure of business secrets and other confidential information. The omissions are MERGER PROCEDURE shown thus […]. Where possible the information omitted has been replaced by ranges of figures or a ARTICLE 6(1)(b) DECISION general description. To the notifying party: Dear Sir/Madam, Subject: Case No COMP/M.6175 - Danaher/ Beckman Coulter Commission decision pursuant to Article 6(1)(b) of Council Regulation No 139/20041 1. On 6 May 2011, the European Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 by which the undertaking Djanet Acquisition Corp. (USA) controlled by Danaher Corporation (USA) ("Danaher") acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of the undertaking Beckman Coulter, Inc. (USA) ("Beckman") by way of public bid announced on 15 February 2011. Danaher and Beckman are designated hereinafter as the "parties (to the proposed transaction)"2. 1 OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation").
    [Show full text]